Task: Answer the multiple choice question.
Query: Which compound exhibits a -1.347\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
[a] COC(=O)c1ccccc1N=Cc1c(O)[nH]c(=O)[nH]c1=O
[b] CCOC(=O)c1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCN(C(C)=O)CC3)c2)cc1
[c] NCCCC[C@H]1CNC(=S)N1CCCCC1CCCCC1
[d] COCc1[nH]nc2c1C1(C(=O)N(C)c3ccccc31)C(C#N)=C(N)O2
Answer: c. NCCCC[C@H]1CNC(=S)N1CCCCC1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
NCCCC[C@H]1CNC(=S)N1CCCCC1CCCCC1
NCCCC[C@H]1CNC(=S)N1CCCCC1CCCCC1
(5S)-5-(4-aminobutyl)-1-(4-cyclohexylbutyl)imidazolidine-2-thione